Institute of Pathology

Grundlagen der Nierenpathologie für Pathologen – Teil 2, Nichtentzündliche Veränderungen (2023) Gaspert A, Büttner-Herold M, Amann KU Journal article Management of Cervical Intraepithelial Neoplasia in Pregnant Women (2023) Stübs F, Koch MC, Dietl A, Schulmeyer C, Behrens A, Seibold A, Adler W, et al. Journal article Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System (2023) Baněčková M, Thompson LD, Hyrcza MD, Vaněček T, Agaimy A, Laco J, Simpson RH, et al. Journal article International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members (2023) Beijert IJ, Cheng L, Liedberg F, Plass K, Williamson SR, Gontero P, Ribal MJ, et al. Journal article Germline C1GALT1C1 mutation causes a multisystem chaperonopathy (2023) Erger F, Aryal RP, Reusch B, Matsumoto Y, Meyer R, Zeng J, Knopp C, et al. Journal article IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management (2023) Czarnywojtek A, Pietronczyk K, Thompson LDR, Triantafyllou A, Florek E, Sawicka-Gutaj N, Ruchala M, et al. Journal article, Review article Large-scale microRNA functional high-throughput screening identifies miR-515-3p and miR-519e-3p as inducers of human cardiomyocyte proliferation (2023) Renikunta HV, Lazarow K, Gong Y, Shukla PC, Nageswaran V, Giral H, Kratzer A, et al. Journal article, Original article Tumor–Stroma Ratio in Colorectal Cancer—Comparison between Human Estimation and Automated Assessment (2023) Firmbach D, Benz M, Kuritcyn P, Bruns V, Lang-Schwarz C, Stübs F, Merkel S, et al. Journal article Immunotherapy in Genitourinary Cancers: Role of Surgical Pathologist for Detection of Immunooncologic Predictive Factors (2023) Bahlinger V, Hartmann A, Eckstein M Journal article, Review article Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041) (2023) Fasching P, Hein A, Kolberg HC, Häberle L, Uhrig S, Rübner M, Belleville E, et al. Journal article